Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Global & Regional Health Technology Assessment
|
January 29, 2024
Agostino Fortunato, Filippo Rumi, Massimo Zazzetta, et al.
Expert Review of Vaccines
|
February 3, 2026
Cost-effectiveness of a single dose of the adjuvanted RSVPreF3 vaccine for the prevention of respiratory syncytial virus (RSV) among patients with chronic obstructive pulmonary disease in Italy
Anna Puggina, Filippo Rumi, Eleftherios Zarkadoulas, et al.
Frontiers in Public Health
|
November 29, 2023
Cost-effectiveness for high dose quadrivalent versus the adjuvanted quadrivalent influenza vaccine in the Italian older adult population
Filippo Rumi, Michele Basile, Americo Cicchetti, et al.
Global & Regional Health Technology Assessment
|
February 6, 2026
Erratum in: Economic evaluation of distribution modalities for ostomy and incontinence medical devices within the Italian healthcare context
Agostino Fortunato, Michele Basile, Debora Antonini, et al.
Global & Regional Health Technology Assessment
|
January 14, 2026
Agostino Fortunato, Michele Basile, Debora Antonini, et al.
Frontiers in Cardiovascular Medicine
|
April 2, 2024
A budget impact model and a cost-utility analysis of reducer device (Neovasc) in patients with refractory angina
Agostino Fortunato, Ilaria Valentini, Filippo Rumi, et al.
Global & Regional Health Technology Assessment
|
January 11, 2023
Michele Basile, Filippo Rumi, Marco Palmeri, et al.
Frontiers in Medical Technology
|
July 5, 2022
A Proposal for Value-Based Managed Entry Agreements in an Environment of Technological Change and Economic Challenge for Publicly Funded Healthcare Systems
Entela Xoxi, Filippo Rumi, Panos Kanavos, et al.
Journal of Medical Economics
|
April 21, 2025
An Italian cost-utility analysis of 20-valent pneumococcal conjugate vaccine for routine vaccination in infants
Michele Basile, Filippo Rumi, Agostino Fortunato, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
June 26, 2025
Cost-effectiveness of treatments for presymptomatic newborn patients with spinal muscular atrophy and two or three copies of the survival motor neuron 2 gene in Italy
Ilaria Valentini, Gianni Ghetti, Marika Pane, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Global & Regional Health Technology Assessment
|
January 29, 2024
Agostino Fortunato, Filippo Rumi, Massimo Zazzetta, et al.
Expert Review of Vaccines
|
February 3, 2026
Cost-effectiveness of a single dose of the adjuvanted RSVPreF3 vaccine for the prevention of respiratory syncytial virus (RSV) among patients with chronic obstructive pulmonary disease in Italy
Anna Puggina, Filippo Rumi, Eleftherios Zarkadoulas, et al.
Frontiers in Public Health
|
November 29, 2023
Cost-effectiveness for high dose quadrivalent versus the adjuvanted quadrivalent influenza vaccine in the Italian older adult population
Filippo Rumi, Michele Basile, Americo Cicchetti, et al.
Global & Regional Health Technology Assessment
|
February 6, 2026
Erratum in: Economic evaluation of distribution modalities for ostomy and incontinence medical devices within the Italian healthcare context
Agostino Fortunato, Michele Basile, Debora Antonini, et al.
Global & Regional Health Technology Assessment
|
January 14, 2026
Agostino Fortunato, Michele Basile, Debora Antonini, et al.
Frontiers in Cardiovascular Medicine
|
April 2, 2024
A budget impact model and a cost-utility analysis of reducer device (Neovasc) in patients with refractory angina
Agostino Fortunato, Ilaria Valentini, Filippo Rumi, et al.
Global & Regional Health Technology Assessment
|
January 11, 2023
Michele Basile, Filippo Rumi, Marco Palmeri, et al.
Frontiers in Medical Technology
|
July 5, 2022
A Proposal for Value-Based Managed Entry Agreements in an Environment of Technological Change and Economic Challenge for Publicly Funded Healthcare Systems
Entela Xoxi, Filippo Rumi, Panos Kanavos, et al.
Journal of Medical Economics
|
April 21, 2025
An Italian cost-utility analysis of 20-valent pneumococcal conjugate vaccine for routine vaccination in infants
Michele Basile, Filippo Rumi, Agostino Fortunato, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
June 26, 2025
Cost-effectiveness of treatments for presymptomatic newborn patients with spinal muscular atrophy and two or three copies of the survival motor neuron 2 gene in Italy
Ilaria Valentini, Gianni Ghetti, Marika Pane, et al.
Page
of 4